Skip to main content

Table 5 Comparison of outcomes between the groups split based on date of cancer occurrence prior to recruitment and incident cancer

From: Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study

Outcome

No malignancy (480)

Malignancy history > 5 years

Group A (47)

Malignancy history < 5 years

Group B (61)

Concurrent/incident malignancy

Group C (52)

p-Value

A vs C

Death

230 (48%)

19 (40.4%)

26 (42.6%)

25 (48.1%)

0.44

Malignancy death

0/111

1/12 (8.3%)

5/14 (35.7%)

5/14 (35.7%)

0.17a

CVD death

53/111 (47.7%)

1/12 (8.3%)

3/14 (21.4%)

3/14 (21.4%)

0.59a

ESRD

131 (27.3%)

13 (27.7%)

17 (27.9%)

15 (28.8%)

0.89

RRT

72 (15%)

11 (23.4%)

9 (14.8%)

8 (15.4%)

0.31

Renal transplants

18 (13.7%)

1/13 (7.7%)

1/17 (5.9%)

2/15 (13.3%)

1.00a

  1. Cause of death available only in 151/300 of matched sample
  2. CVD cardiovascular disease, ESRD end-stage renal disease, RRT renal replacement therapy
  3. p-Value by Chi-square test. ap-Value by Fisher exact test